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Edited by Ulrike KutayAbstract The interaction of proteins with ubiquitin receptors is
key to solving the mystery that surrounds the functional role
ubiquitin chains play in directing traﬃc. The speciﬁcity of these
interactions is largely mediated by UbL/UBA domains. Seques-
tosome 1/p62 is a protein that is gaining attention as it is inti-
mately involved in cell signaling, receptor internalization, and
protein turnover. Herein we review recent advances in the ﬁeld.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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kinase C1. Overview
The UbL/UBA family of proteins is a rapidly expanding
group involved in a diverse set of cellular functions. Members
of this family have been shown to transport ubiquitinated car-
go for degradation, and protect other proteins from degrada-
tion by sequestration of polyubiquitin chains. In
Saccharomyces cerevisiae, Rad23, Dsk2, and Ddi1 shuttle
ubiquitinated proteins to the 26S proteasome for degradation.
This is accomplished by interaction of their UBA domains
with ubiquitinated substrates and binding of their N-terminal
UbL domains with the proteasome [1]. Conversely, the
Rad23 UBA2 domain sequesters K48 polyubiquitin chains
preventing their elongation or de-ubiquitination, which blocks
substrate degradation [2]. UBA domains have also been impli-
cated in protecting UbL/UBA family members from their own
degradation via the proteasome. Rad23 and Ddi1 heterodimer-
ize by interaction of their respective UbL and UBA domains
this interaction results in enhanced binding of polyubiquitin
[3].2. Functional properties
2.1. Self association – PB1 domain
Sequestosome (SQSTM) 1/p62, a co-interacting protein of
the atypical PKC isoforms f/i [4,5], has a UBA domain at its
C-terminal end, which binds non-covalently to polyubiquitin*Corresponding author.
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doi:10.1016/j.febslet.2006.12.027chains. Several other protein interaction domains exist within
p62 suggesting a possible role in the formation of multimeric
signaling complexes [6]. At its N-terminus, p62 has a PB1
domain [7], which shares considerable structural homology
with the UbL domain [8] and has been shown to interact with
the 26S proteasome subunit Rpt1 [9]. Thus, p62 can serve as a
shuttling factor that directs polyubiquitinated proteins inter-
acting with the UBA domain for turnover [9].The PB1 (Phox
and Bem1p) domain is a protein–protein interaction domain
present in 29 human proteins, including p40phox, p67phox,
aPKC k/i and f, Par6, MEK5 and SQSTM1/p62 [10]. Proteins
containing PB1 domains can form speciﬁc heterodimers be-
tween family members. Critical residues involved in this pro-
tein–protein interaction have been identiﬁed. A ‘‘basic
cluster’’ of conserved Lys and Arg residues in one PB1 domain
interacts with the highly conserved acidic OPCA motif of an-
other in a front-to-back interaction topology [7]. Based on
their domain architecture, three broad classes of PB1 domains
have been identiﬁed (Fig. 1a) [10]. Type A PB1 domain pro-
teins have the canonical OPCA motif but lack the basic cluster.
By contrast, Type B family members possess the basic cluster
but lack the OPCA motif. Type A and Type B PB1 domains
can interact to form heterodimers; however, not all B-type
domains interact with all A-type domains or vice versa. It is
possible that non-conserved PB1–PB1 interactions confer the
high speciﬁcity of heterodimerization reported between family
members. A small group of PB1 domain proteins, aPKC, Par6
and p62, contain both the basic cluster and the OPCA motif
[10]. The basic cluster of p62 interacts with the OPCA motif
of aPKC [7]. In this conﬁguration, both the OPCA motif of
p62 and the basic cluster of aPKC are free and may interact
with other PB1 domains, including that of p62 itself. In fact,
p62 oligomerization has been observed where the basic cluster
of one p62 molecule binds to the OPCA motif of another in a
front-to-back arrangement [10]. p62 has been shown to seques-
ter polyubiquitin into sequestosomes or aggresomes [11], there-
in, interactions between p62 molecules may enhance the size of
the aggresomes. In this regard, p62’s UBA domain is necessary
for recruitment of polyubiquitin and aggresome formation [9].
Alternatively, p62 may be required either directly for forma-
tion of aggresomes or for a process whose inhibition indirectly
disrupts the formation of aggresomes. The physiological rele-
vance of aggresomes is still a matter of debate. However, they
are a common pathological feature in diseases that aﬀect brain,
muscle, and liver [12,13].
The structure of the PB1 domain reveals an ubiquitin-like
fold topology similar to the structure of the UbL domain [8].blished by Elsevier B.V. All rights reserved.
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Fig. 1. Functional properties of p62 UbL and UBA domains. (a) PB1
domains can be one of three types: Type A, Type B, or Type A/B. p62
interacts with aPKC and can also dimerize with another p62 molecule
via back-to-back binding of the basic cluster and the OPCA motif
within the PB1 domain. (b) The ‘‘MGF’’ binding pocket of p62’s UBA
domain accommodates polyubiquitin binding. Location of p62 UBA
mutations, F406V and L413V. (c) UBA domain mutants were tested
for their ability to bind polyubiquitin chains in a GST-UBA pulldown
and Western blotting for ubiquitin (Ub), upper panel. p62 turnover
was assessed by transiently transfecting HEK cells with myc-tagged
p62 UBA domain mutants. Following overnight incubation, cells were
treated with cyclohexamide for 24 h. Lysates were prepared immedi-
ately after treatment 0, or after 3 h the expression of p62 was
monitored by Western blotting for myc. (d) The UBA domain of p62
bind both K48 and K63 polyubiquitin chains [19]. GST-tagged p62
UBA domain was used in a pulldown assay along with increasing
concentrations of either K48 or K63 polyubiquitin chains (kindly
provided by Cecile Pickart).
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its UbL domain with the UIM motif of the Rpn10 subunit of
the proteasome [14]. Similarly, Dsk2 UbL domain interacts
with the Rpn1 subunit of the 19S regulatory proteasomal sub-
complex [14]. p62 has been reported to interact with the protea-
some by binding to the S5a subunit (homologous to Rpn10 in
yeast) via its N-terminus [9]. Thus, p62 may function in the for-
mation of multimeric protein complexes because of the interac-
tions of its PB1 domain with other proteins and it may also play
a role in protein turnover due to its association with the protea-
some. The PB1 domain may possess a ﬂexible functional role,
either favoring formation of self-associating p62 molecules that
promote formation of aggresomes, or by interaction with other
molecules that deﬁne speciﬁc cellular functions.
2.2. Interaction with polyubiquitin
The UBA domain was originally identiﬁed by a bioinformat-
ics analysis and is found in many proteins in the ubiquitin/pro-teasome pathway [15]. Most proteins containing UBA domains
bind ubiquitin and display a preference for polyubiquitin
chains [16]. The UBA structure reveals a three-helix bundle
(Fig. 1b) with a conserved hydrophobic patch, MGF, that is
necessary for interaction with polyubiquitin [17]. The interac-
tion of the UBA domain with polyubiquitin protects Rad23
from proteolytic degradation and extends the half-life of the
protein [2]. Mutation of F406V within p62’s UBA core domain
prevents interaction with polyubiquitin chains [9] and likewise
shortens the half-life of p62 (Fig. 1c). In comparison, mutation
of L413V which does not disrupt polyubiquitin binding ability
of the UBA domain has little eﬀect on p62’s half-life (Fig. 1c).
Therefore polyubiquitin binding may serve as a stabilization
signal to extend the half-life of the protein and to prolong the
functional role of p62. This may be a common and conserved
eﬀect that polyubiquitin binding has upon all proteins which
possess a UBA domain.
While K48 polyubiquitin chains are the most common signal
for proteasomal degradation, chains can form on any of the
seven lysine residues in the ubiquitin molecule [18]. Rad23
and Dsk2 bind K48-linked chains in vivo and are intimately
involved in the protein degradation pathway. However, a
recent in vitro survey found little selectivity of either UBA
domain for K48 compared to K63 chains [19]. This observa-
tion suggests that other structural determinants exist in the
holo-protein that enables chain-selective interactions. In this
regard, we have observed that p62’s UBA domain binds both
K48 and K63 polyubiquitin chains in an in vitro pull down as-
say (Fig. 1d). Nonetheless, p62 selectively regulates the exten-
sion of K63 polyubiquitin chains on to substrates in vivo by its
interaction with the E3 ubiquitin ligase, TRAF6, an enzyme
that synthesizes K63 chains in vivo [20]. Interaction of E3
ubiquitin ligases with their respective scaﬀolding proteins likely
serves as a mechanism whereby chains are transferred to target
substrates. Both p62 and TRAF6 have been co-localized to
discrete punctate structures upon stimulation of p62 signaling
pathways [21]. These sites may localize inactive complexes in
the cell, whereas active signal complexes of TRAF6-p62 may
reside in the cytoplasm [22].2.3. Scaﬀolding
The neurotrophin receptor, TrkA, is a substrate of TRAF6
and upon binding of NGF, leads to formation of a multimeric
signal complex consisting of TrkA, TRAF6 and p62 [23]. In
fact, TRAF6 K63-polyubiquitination of TrkA is necessary
for internalization and sorting of the receptor. These ﬁndings
reveal that p62 serves as a scaﬀold to regulate K63 polyubiqui-
tination via interaction with TRAF6. Interestingly, loss of p62
interaction/dimerization aﬀects TRAF6 K63-autoubiquitina-
tion/activation as well [20]. Therefore, p62-TRAF6 interac-
tions may induce a conformational change in p62’s UBA
domain allowing the subsequent interaction with speciﬁc poly-
ubiquitinated substrates. A number of factors likely contribute
to the functional speciﬁcity of the UBA domain in vivo. This
idea is further strengthened by recent evidence that when
bound to substrate, polyubiquitin chains can change their con-
formation to accommodate multiple UBA domains [24].
Previously, p62 was found to be necessary for TRAF6-
dependent activation of NF-jB [20]. The activity of TRAF6
is regulated by autoubiquitination. Cells devoid of p62 exhibit
low basal TRAF6 polyubiquitination. However, when p62 is
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has also been conﬁrmed using p62/ mice in which the
absence of p62 reduced activation of TRAF6. Deletion con-
structs that remove the PB1 domain, UBA domain or TRAF6
binding domain reveal that each is necessary for activation of
NF-jB or TRAF6 [20]. Dimerization of p62 through its N-ter-
minus is also necessary for TRAF6 activation. Together, the
three protein interaction modules, PB1, TRAF6, and UBA,
play a coordinated role in the activation and regulation of
TRAF6 (Fig. 2a).
Naturally occurring isoforms of p62 (ZIP2, ZIP3) exist [25].
ZIP2 lacks the TRAF6 binding site required for oligomeriza-
tion and ZIP3 lacks a UBA domain needed for binding poly-
ubiquitin [26]. It is plausible to infer that either of these
isoforms could play a deﬁned cellular role in regulating
TRAF6 activation by preventing TRAF6 from being recruitedFig. 2. Models of p62 function. (a) p62 can act as a scaﬀold for the
K63 polyubiquitination of TRAF6 speciﬁc substrates. In a native
form, the UbL domain of p62 may interact with its UBA domain,
prior to interaction with ubiquitin. Next, the protein may ‘‘open’’
allowing access to multiple protein binding domains. Following p62
dimerization through the PB1 domain, dimerized TRAF6 binds to p62
at the TRAF6-binding site allowing the transfer of K63 polyubiquitin
chains generated from TRAF6 to speciﬁc substrates. K63-tagged
substrates can interact with the UBA domain of p62. (b) p62 may
reside at the intersection of two degradation pathways. Once the
polyubiquitin chain of a substrate protein binds to the UBA domain of
p62, the substrate can be traﬃcked to the proteasome for degradation.
An example of this is the p62-dependent turnover of tau which requires
p62 for proteasomal degradation [21]. p62 may also be involved the
autophagic/lysosomal pathway by sequestering aggregated proteins
prior to their inclusion in autophagosomes.to a p62 signaling scaﬀold or by disrupting the formation of
K63 polyubiquitin chains necessary for TRAF6-dependent
ubiquitination of targeted substrates. Diversity in regulation
of TRAF6 activation may occur in a tissue-speciﬁc manner
depending upon the expression of p62 isoforms. Adding fur-
ther complexity to the situation, ZIP2 exerts a dominant-neg-
ative eﬀect on p62/ZIP1 function [20].2.4. Movement of cargo
p62 also serves as a shuttling factor for delivery of polyubiq-
uitinated substrates, like tau, to the proteasome [21]. We found
that p62 binds to the S5a subunit of the proteasome [9] by
interaction of its N-terminal PB1 domain with S5a, while its
UBA domain interacts with polyubiquitinated tau [21]. This
is the ﬁrst reported example of p62 serving a shuttling function
similar to other UbL/UBA family members [27]. Post-ubiquiti-
nation, the substrate complex is shuttled to the proteasome for
degradation (Fig. 2b). The accumulation of hyperphosphoryl-
ated and aggregated tau is a hallmark of neurodegenerative
disease. Interestingly, p62 has been localized with tau in tan-
gles [12], which suggests a possible functional interaction in
clearance of tau in vivo.
Recently, the N-terminus of p62 has also been shown to
interact with LC3, a marker of the autophagocytic vesicle [re-
viewed in 28]. Autophagy is a bulk process whereby cytoplasm
and organelles are delivered to the lysosome for degradation. It
is possible that p62 may play a role in selective sequestration of
polyubiquitinated proteins for autophagy. Thus, p62 may exist
at the intersection of the endocytosis, proteasome, and auto-
phagosome networks (Fig. 2b).3. Questions that remain
What deﬁnes the speciﬁcity of the interactions of p62? Orig-
inally identiﬁed as an aPKC interacting protein [4,5], p62 was
shown to interact with aPKC through binding of their respec-
tive PB1 domains [7]. However, the p62 PB1 domain has also
been shown to interact with other proteins such as MEK5,
NBR1 and LC3. Also, p62 dimerizes through interactions of
its PB1 domain with that of another p62 molecule [7]. A model
could be envisioned where competition for PB1 domain binding
between all these diﬀerent players leads to diversity in signaling
pathways and/or the intracellular localization of p62. However,
any eﬀects of p62 binding partners can not be discounted in reg-
ulation of interactions with the PB1 domain. Monoubiquitina-
tion of either Sts1or Sts2 regulates their ability to bind
ubiquitinated cargo in trans [29]. Therefore, a similar mecha-
nism may exist for p62 as a means to regulate interaction with
its cargo. In this regard, several naturally occurring variants of
the p62 UBA domain have been linked with Paget’s disease of
the bone [30]. These mutants may cause pleiotropic eﬀects with
functional consequences upon polyubiquitin binding the UBA
domain. For example, mutations in the UBA domain may alter
binding of polyubiquitin [9], impair activation of TRAF6 [20],
disrupt interaction with cargo, alter formation of aggresomes
[9], or block the turnover of p62 (Fig. 1c). Moreover, the exten-
sion of polyubiquitin chain by TRAF6 onto a target substrate is
dependent upon the ubiquitin binding capabilities of the UBA
domain (Fig. 3). Deletion of p62’s UBA domain, or mutations
within the UBA domain which impair interaction of p62 with
Fig. 3. Interaction of polyubiquitin with p62 UBA is necessary for
substrate ubiquitination. PC12 cells were transfected with Myc-tagged
wild-type (WT) p62, Myc-p62 DUBA (a construct lacking the UBA
domain), Myc-p62 UBA mutant 1: L398V (no eﬀect on poly-
ubiquitin binding), Myc-p62 UBA mutant 2: F406V (inhibits poly-
ubiquitin binding); or Myc-p62 UBA mutant 4: L417V (inhibits
polyubiquitin binding). Complete characterization of the mutants and
the eﬀects on binding polyubiquitin has been previously described [9].
Thirty-six hours after transfection the cells were treated with NGF
(50 ng/ml) for 15 min, lysed and immunoprecipitated with TrkA
antibody [23], followed by Western blotting for either ubiquitin or
TrkA as shown.
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mutations that are without aﬀect on polyubiquitin binding have
no eﬀect on TrkA polyubiquitination. These ﬁndings suggest
that p62’s UBA domain carries polyubiquitin chains not only
necessary for activation of TRAF6 [20], but that these chains
are transferred to the substrate (Fig. 2a). In keeping with this
observation we have observed that inhibition of p62/TRAF6
interaction prevented TrkA polyubiquitination as well [23].
Recent studies have shown that Dsk2’s UbL domain inter-
acts with its UBA domain [31]. While the UbL–UBA interac-
tion is relatively weak compared to the binding of ubiquitin to
the UBA domain, it is possible to propose a model for the reg-
ulatory mechanism of Dsk2’s adaptor/shuttling function. The
protein may be in a closed conﬁguration until ubiquitin is
introduced and the UbL domain is competed away from the
UBA domain making it available for interaction with the pro-
teasome, and allowing Dsk2 to carry its ‘‘cargo’’ for proteo-
lytic degradation [31]. Indeed a similar model may enable
p62 to adopt a closed conformation, where the ubiquitin fold
of the PB1 domain competes for UBA binding, another level
of speciﬁcity might be achieved. Displacement of the UbL
domain from the UBA domain may then enable p62 to interact
with its various binding partners with monoubiquitination ter-
minating this interaction [29]. How might this conformational
change be achieved? One obvious regulator is interaction with
TRAF6. However, one should also consider the role of the
atypical PKCs (i/k and f) in this process. Studies by Puls
et al. [4] revealed that p62 aggregates were increased in the
absence of aPKC/p62 interaction, whereas aPKC regulated
the cytosolic localization of p62. Therefore, aPKC emerges
as a critical factor of aggresome formation and may regulate
the functional localization of p62, as well as, its ability to inter-
act with polyubiquitin. Further studies are needed to explore
consequences of aPKC/TRAF6/p62 interactions.
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